6533b7d0fe1ef96bd125a580
RESEARCH PRODUCT
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:current status in 37 ESC countries
William WijnsBéla MerkelyStefan JamesSteen Dalby KristensenMarc J. ClaeysPeter ClemmensenDan DeleanuOlli A. KajanderManel SabatéJohn KanakakisPetr WidimskyDariusz DudekVaja AgladzePetr KalaCarlo Di MarioKim Wadt HansenS. WahlerFrancesca A. NicoliniMohamed SobhyJean FajadetDragana RadovanovicSiobhan JenningsRuslan NajafovKiril K. KaramfiloffMartine GilardDavor MilicicDavor MilicicAndrejs ĒRglisKristina G. LautRan KornowskiSasko KedevOmer GoktekinThorarinn GudnasonGiulio GuagliumiPeter LudmanMartin StudencanZuzana KaifoszovaKurt HuberMarko NocMenko-jan De BoerTomáš JanotaIbrahim TerzicMaxim V. SokolovMiodrag OstojicKhalid F. AlhabibLoizos AntoniadesHélder Pereirasubject
AdultMalemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentVascular damage Radboud Institute for Health Sciences [Radboudumc 16]PopulationCardiologyMyocardial Infarctionacute myocardial infarction610 Medicine & healthMyocardial ReperfusionPercutaneous Coronary InterventionReperfusion therapyHumansMedicineThrombolytic TherapyIn patientHospital MortalityRegistriescardiovascular diseasesMyocardial infarctioneducationAgededucation.field_of_studybusiness.industryST elevationCoronary Care UnitsPercutaneous coronary interventionThrombolysisMiddle Agedmedicine.disease3. Good healthEuropeCross-Sectional Studiessurgical procedures operativeEmergency medicineWorkforceFemaleHuman medicineMedical emergencyCardiology and Cardiovascular Medicinebusinessdescription
Item does not contain fulltext AIMS: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. METHODS AND RESULTS: A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. CONCLUSION: Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2014-08-01 |